From: Clinical significance of p27 Kip1 expression in advanced ovarian cancer
 | No. |  | RNA | IHC | X2 | P | ||
---|---|---|---|---|---|---|---|---|
Stage | Â | No | % | No | % | Â | Â | |
IIIA | 10 | Uprega or positive IHCb | 8 | 80 | 8 | 80 | 0.313 | 0.576 |
Downreg.c or negative IHC | 2 | 20 | 2 | 20 | ||||
IIIB | 12 | Upreg or positive IHC | 10 | 83.3 | 10 | 83.3 | 0.3 | 0.584 |
Downreg. or negative IHC | 2 | 16.7 | 2 | 16.7 | ||||
IIIC | 66 | Upreg or positive IHC | 42 | 63.6 | 42 | 63.6 | 0.033 | 0.856 |
Downreg. or negative IHC | 24 | 36.4 | 24 | 36.4 | ||||
Grade | ||||||||
Mod. + Welld | 30 | Upreg or positive IHC | 26 | 86.7 | 26 | 86.7 | 0.144 | 0.704 |
Downreg. or negative IHC | 4 | 13.3 | 4 | 13.3 | ||||
Poor | 58 | Upreg or positive IHC | 16 | 27.6 | 16 | 27.6 | 0.043 | 0.835 |
Downreg. or negative IHC | 42 | 72.4 | 42 | 72.4 | ||||
Pathology | ||||||||
serous | 64 | Upreg or positive IHC | 43 | 67.2 | 38 | 59.4 | 0.538 | 0.463 |
Downreg. or negative IHC | 21 | 32.8 | 26 | 40.6 | ||||
NSe | 24 | Upreg or positive IHC | 2 | 8.3 | 4 | 16.7 | 0.19 | 0.663 |
Downreg. or negative IHC | 22 | 91.7 | 20 | 83.3 | ||||
Ascites | ||||||||
present | 60 | Upreg or positive IHC | 14 | 23.3 | 18 | 30 | 0.384 | 0.536 |
Downreg. or negative IHC | 46 | 76.7 | 42 | 70 | ||||
absent | 28 | Upreg or positive IHC | 24 | 85.7 | 24 | 85.7 | 0.146 | 0.703 |
Downreg. or negative IHC | 4 | 14.3 | 4 | 14.3 | ||||
Resid Disf | ||||||||
>  2 cm | 60 | Upreg or positive IHC | 15 | 25 | 18 | 30 | 0.167 | 0.683 |
Downreg. or negative IHC | 45 | 75 | 42 | 70 | ||||
<  2 cm | 28 | Upreg or positive IHC | 21 | 75 | 24 | 85.7 | 0.453 | 0.501 |
Downreg. or negative IHC | 7 | 25 | 4 | 14.3 | ||||
Response | ||||||||
CR, Micro dis., PRg | 46 | Upreg or positive IHC | 41 | 89.1 | 40 | 87 | 0 | >.999 |
Downreg. or negative IHC | 5 | 10.9 | 6 | 13 | ||||
NR or progressive dis.h | 42 | Upreg or positive IHC | 1 | 2.4 | 2 | 4.8 | 0 | >.999 |
Downreg. or negative IHC | 41 | 97.6 | 40 | 95.2 |